Background: Surgical treatment of stage I non-small cell lung cancer (NSCLC) can be performed either by thoracotomy or by employing video-assisted thoracic surgery (VATS). The aim of this study was to evaluate the feasibility of VATS lobectomy for pathologic stage I NSCLC. Material and Methods: Between December 2003 and December 2007, 529 patients with pathologic stage I NSCLC underwent lobectomies (373 thoracotomy, 156 VATS). Patients in both groups were selected after being matched by age, gender and pathologic stage using propensity score method, to create two comparable groups: thoracotomy and VATS groups, and the overall survival, recurrence-free survival, complication and length of hospitalization were compared between these two groups. Results: After the patients were matched by age, gender and pathologic stage, 272 patients remained eligible for analysis, 136 in each group (mean age of 59.5 years; 70 men, 66 women; 80 stage IA, 56 stage IB). There was no statistical difference in other preoperative clinical characteristics between the two groups. No hospital mortality was observed in both groups. Overall 3-year survival rate was 97.4% in thoracotomy group and 96.6% in VATS groups (p=0.76). During the follow-up, 20 patients (14.7%) developed recurrence in thoracotomy group, including loco-regional recurrence in 7, distant metastasis in 13. In VATS group, 13 patients (9.6%) developed recurrence, including loco-regional recurrence in 4, distant metastasis in 9. Three-year recurrence-free survival rate was 81.8% in thoracotomy group and 85.3% in VATS groups (p=0.43). There was no significant difference in postoperative complications between thoracotomy and VATS groups (30 cases in 22 patients vs. 19 cases in 17 patients, p=0.65, odds ratio=1.19). The mean hospital stay of VATS group was 2 days shorter than that of thoracotomy group (8.8±6.5 days vs. 6.3±3.3 days, p＜0.05). Conclusion: VATS lobectomy for pathologic stage I lung cancer is a feasible operation with shorter hospitalization, while surgical outcome is comparable to thoracotomy lobectomy.
INTRODUCTION
Since video-assisted thoracoscopic surgery (VATS) lobectomy was introduced in the early 1990s, its use in the treatment of non-small cell lung cancer (NSCLC) has been gradu- [1] . Therefore, evidence-based information on VATS lobectomy, regarding not only the safety and technical feasibility but also the oncological outcome, should be accumulated more for this novel approach widely accepted as a standard procedure for early-stage NSCLC.
In our institution, VATS lobectomy was adopted in the early 2000s, and has been performed with a gradual increase, for the treatment of both benign lung disease and early-stage non-small cell lung cancer. The aim of this study is to evaluate the feasibility and surgical outcome of VATS lobectomy compared to conventional open-thoracotomy, based on our experience of pathologic stage I NSCLC. Descriptive statistics were used to describe the patients' characteristics and outcomes. The normally distributed continuous data were expressed as means±standard deviations.
MATERIAL AND METHODS

Between
Categorical data were expressed as counts and proportions. VATS=Video-assisted thoracic surgery.
these variables between the two groups.
There were 2 operative mortality in the entire VATS lobectomy group during the same period (2/268, 0.74%), and one with pathologic stage I was excluded from the analysis during the matching process. In the two matching groups, there was no in-hospital mortality related to the operation. with distant metastasis. In VATS group, 13 patients (13/136, 9.6%) experienced tumor recurrence, including 4 with loco-regional recurrence and 9 with distant metastasis. Table 3 shows the recurrence pattern of each group, according to pathologic stage.
Three-year recurrence-free survival was 81.8% in open-thoracotomy group and 85.3% in VATS group. There was no significant difference in recurrence between the two groups (p=0.43) (Fig. 2) . 
DISCUSSION
